Sildenafil Tablet, Film Coated
Product Images NDC 33342-536

9 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 33342-536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Sildenafil Str)

Str (Sildenafil Str)
Chemical structure of Sildenafil depicted, showing its molecular arrangement including heterocyclic rings, methyl groups, and carboxyl functional groups consistent with the active ingredient Sildenafil.*
FDA Label Image

505 (Sildenafil Figure 1)

505 (Sildenafil Figure 1)
A chart illustrating fold change and 90% confidence intervals of area under the curve (AUC) and maximum concentration (Cmax) for various drugs when coadministered with Sildenafil. The vertical line at 1 represents no change relative to Sildenafil alone. Recommendations on dose adjustment and coadministration are provided for each interacting drug listed, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir.*
FDA Label Image

505 (Sildenafil Figure 2)

505 (Sildenafil Figure 2)
A horizontal error bar chart illustrating the fold change and 90% confidence intervals for various interacting drugs when combined with sildenafil. The chart compares parameters such as AUC, Cmax, INR, and bleeding time, with recommendations for dose adjustments ranging from "No dose adjustment" to "Coadministration not recommended."*
FDA Label Image

505 (Sildenafil Figure 3)

505 (Sildenafil Figure 3)
A line graph showing the change from baseline in 6-minute walk distance (meters) at weeks 4, 8, and 12 in the SUPER-1 study. The graph includes data for Sildenafil 40 mg TID, Sildenafil 80 mg TID, and placebo groups, with mean values and 95% confidence intervals plotted over the weeks of study.*
FDA Label Image

505 (Sildenafil Figure 4)

505 (Sildenafil Figure 4)
A horizontal dot plot graph showing placebo-corrected changes in 6-minute walk distance for Sildenafil 20 mg TID compared to placebo. The graph is divided into subgroups by baseline walk distance, etiology, PH criteria, gender, age, mean PAP, and PVR. Each subgroup has data points with confidence intervals for placebo and Sildenafil, illustrating treatment effects across different patient categories.*
FDA Label Image

505 (Sildenafil Figure 5)

505 (Sildenafil Figure 5)
A line graph illustrating the percentage of subjects without a clinically worsening event over time, comparing placebo and Sildenafil groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without event (0 to 100%). The Sildenafil group maintains a higher percentage without worsening events compared to the placebo group throughout the study period.*
FDA Label Image

222 (Sildenafil Tablets 20mg 90s)

222 (Sildenafil Tablets 20mg 90s)
Sildenafil Tablets, USP 20 mg film-coated tablet label from Macleods Pharmaceuticals Limited. The label shows the product name, strength, and specifies 90 tablets per package. It includes storage instructions, manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. India, and an NDC barcode.*
FDA Label Image

505 (Sildenafil Foil)

505 (Sildenafil Foil)
Label sheet for Sildenafil 20 mg tablets by Macleods Pharmaceuticals Limited. Each label indicates the product name, strength (20 mg), film-coated tablet dosage form, manufacturer information, and includes a barcode. The labels are repeated multiple times on the sheet, showing consistent branding and packaging details for this oral prescription drug.*
FDA Label Image

222 (Sildenafil Tablets 20 mg)

222 (Sildenafil Tablets 20 mg)
Sildenafil Tablets, USP 20 mg film-coated tablets packaging label from Macleods Pharmaceuticals Limited. The label indicates each box contains 100 tablets (10 x 10) and includes storage instructions, manufacturer details, and a barcode. The label specifies the dosage form as oral tablets and highlights the 20 mg strength prominently.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.